Carmat (ALCAR)

Business description

Carmat is developing a biocompatible, artificial heart to satisfy the lack of donor hearts available for terminal heart failure patients. The development process combines the expertise of a wide range of technical and medical experts.

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 12/02/2015

Edison's research is freely available. We will never ask for your credit card details and you do not need to register. By downloading this research you are agreeing to our terms and conditions, which you can read in full here.

Stock data

Market cap.€187.5m
Last close€20.800
High / Low (52 weeks)€29.6 / €19.9
Stock market listingEG
Forecast net cash (€m)54.5
Forecast gearing ratio (%)N/A
TeamHealthcare
SectorPharmaceutical & healthcare

Price performance

%1m3m12m
Actual(3.5)(4.6)(29.3)
Relative *(7.1)(9.8)(33.6)

* % Relative to local index

Company news

Carmat

Fri, 09 Mar 2018 12:22:30 GMT

Carmat

Wed, 16 May 2018 11:26:15 GMT

Carmat

Mon, 23 Oct 2017 17:03:45 GMT

Carmat

Tue, 24 Oct 2017 08:52:02 GMT

Carmat

Mon, 17 Mar 2014 11:02:02 GMT